THE IMPACT OF LIRAGLUTIDE ON PATIENTS WITH METABOLIC DYSFUNCTION ASSOCIATED FATTY LIVER DISEASE

被引:0
|
作者
Lee, Hye Won [1 ]
So, Jae Eun [1 ]
Ahn, Sang Hoon [1 ]
Kim, Seung Up [1 ]
机构
[1] Yonsei Univ, Coll Med, Seoul, South Korea
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1619
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Impact of anthropometric parameters on outcomes in Asians with metabolic dysfunction-associated fatty liver disease
    Choi, Kyu Yeon
    Kim, Tae Yeon
    Chon, Young Eun
    Kim, Mi Na
    Lee, Joo Ho
    Hwang, Seong Gyu
    Lee, Jiwoo
    Kwak, Mi Kyung
    Hong, Eun-Gyoung
    Choi, Yun Mi
    Ha, Yeonjung
    JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2023, 14 (06) : 2747 - 2756
  • [22] LIVER FIBROSIS IN ASIANS WITH METABOLIC DYSFUNCTION-ASSOCIATED FATTY LIVER DISEASE
    Kim, Byung Ik
    Sohn, Won
    Kwon, Heon-Ju
    Cho, Yong Kyun
    HEPATOLOGY, 2021, 74 : 1022A - 1022A
  • [23] Liver Fibrosis in Asians With Metabolic Dysfunction-Associated Fatty Liver Disease
    Sohn, Won
    Kwon, Heon-Ju
    Chang, Yoosoo
    Ryu, Seungho
    Cho, Yong Kyun
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (05) : E1135 - E1148
  • [24] Metabolic (dysfunction)-associated fatty liver disease metrics and contributions to liver research
    Suoh, Maito
    Esmaili, Saeed
    Eslam, Mohammed
    George, Jacob
    HEPATOLOGY INTERNATIONAL, 2024, 18 (06) : 1740 - 1755
  • [25] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    Han, A. Lum
    DIABETOLOGY & METABOLIC SYNDROME, 2022, 14 (01):
  • [26] Validation of fatty liver index as a marker for metabolic dysfunction-associated fatty liver disease
    A Lum Han
    Diabetology & Metabolic Syndrome, 14
  • [27] THE CHARACTERISTIC OF LIVER INFLAMMATION IN PATIENTS WITH METABOLIC- (DYSFUNCTION) ASSOCIATED FATTY LIVER DISEASE IN DIFFERENT SUBTYPES
    Wang, Yu
    Liu, Zi-Yu
    Dai, Ming-Jia
    Ji, Fang
    Li, Jian-Zhong
    Rui-Huang
    Wu, Chao
    Yan, Xuebing
    ACTA MEDICA MEDITERRANEA, 2023, 39 (02): : 551 - 556
  • [28] The impact of metabolic dysfunction-associated fatty liver disease on the prognosis of patients with hepatocellular carcinoma after radical resection
    Xiong, Ke-Gong
    Ke, Kun-Yu
    Chen, Li-Fang
    Kong, Jin-Feng
    Lin, Tai-Shun
    Lin, Qing-Biao
    Lin, Su
    Zhu, Yue-Yong
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2023, 22 (04) : 366 - 372
  • [29] Association of metabolic dysfunction-associated fatty liver disease with kidney disease
    Ting-Yao Wang
    Rui-Fang Wang
    Zhi-Ying Bu
    Giovanni Targher
    Christopher D. Byrne
    Dan-Qin Sun
    Ming-Hua Zheng
    Nature Reviews Nephrology, 2022, 18 : 259 - 268
  • [30] The Janus of a disease: Diabetes and metabolic dysfunction-associated fatty liver disease
    Barrera, Francisco
    Uribe, Javier
    Olvares, Nixa
    Huerta, Paula
    Cabrera, Daniel
    Romero-Gomez, Manuel
    ANNALS OF HEPATOLOGY, 2024, 29 (04)